You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Radiation Therapy
 •Melanoma
 •Surgical Oncology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Melanoma of the Clavicular Region

Multimodal Treatment

Linh Lam, MD; Edward Krementz, MD; Clifton McGinness, MD; Richard Godfrey, MD

Arch Surg. 2001;136:1054-1058.

Hypothesis  Treatment for melanoma that has metastasized to the supraclavicular nodes should be intensive and use a multimodality approach.

Design  Retrospective analysis of clinical records.

Setting  Six primary care centers, 2 of which were referral centers.

Patients  Eighteen patients diagnosed as having a rare pattern of advanced melanoma metastatic to the clavicular region.

Intervention  Combined radiotherapy, chemotherapy, and thorough surgical excision of the affected nodal basins.

Main Outcome Measure  Length of survival from time of diagnosis and treatment to time of follow-up.

Results  Median survival among the 18 patients was 28 months with a 22% survival rate at 5 years after diagnosis. Among patients who received radiotherapy to the clavicular node basin, mean length of survival was 88.7 months with a 50% 5-year survival rate compared with a mean length of survival of 33.8 months and an 8.3% 5-year survival rate in patients who did not receive radiotherapy (P<.001). Mean survival among patients who had supraclavicular node dissection was 45.8 months with a 23.1% survival rate at 5 years after diagnosis, compared with a mean survival of 52 months and a 20% 5-year survival rate among patients who did not receive therapeutic lymphadenectomy. Of the 11 patients who had therapeutic lymphadenectomy, 2 also received radiotherapy to the supraclavicular nodal basin and continued to be disease-free at 82 and 130 months. All long-term survivors had been treated with intra-arterial chemotherapy.

Conclusion  In a series of patients with malignant melanoma metastatic to the clavicular lymph nodes, multimodality treatment using radiotherapy, chemotherapy, and thorough surgical excision of affected nodal basins provided an appreciable 5-year survival rate.


From the Departments of Surgery, Tulane University Medical Center (Dr Krementz) and Memorial Medical Center (Dr McGinness), New Orleans, La; and Kaiser Permanente Medical Center, Oakland, Calif (Drs Lam and Godfrey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.